Novartis Ends Hypertension DTC Campaign After FDA Objects To Diovan Link
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis has discontinued its unbranded direct-to-consumer advertising campaign on hypertension awareness following objections by FDA